scholarly journals Discovery of Non‐racemic Amisulpride to Maximize Benefit/Risk of 5‐HT7 and D2 Receptor Antagonism for the Treatment of Mood Disorders

2021 ◽  
Author(s):  
Seth C. Hopkins ◽  
Scott Wilkinson ◽  
Taryn J. Corriveau ◽  
Hiroyuki Nishikawa ◽  
Keiko Nakamichi ◽  
...  
Keyword(s):  
Mood Disorders ◽  
D2 Receptor ◽  
Receptor Antagonism

scholarly journals Dopamine D1 and D2 receptor antagonism effects on rat ultrasonic vocalizations

2013 ◽  
Vol 252 ◽  
pp. 252-259 ◽  
Author(s):  
Lauren E. Ringel ◽  
Jaime N. Basken ◽  
Laura M. Grant ◽  
Michelle R. Ciucci
Keyword(s):  
D2 Receptor ◽  
Ultrasonic Vocalizations ◽  
Receptor Antagonism

scholarly journals Dopamine D2 Receptor Antagonism Suppresses Tau Aggregation and Neurotoxicity

2013 ◽  
Vol 73 (5) ◽  
pp. 464-471 ◽  
Author(s):  
Allyson V. McCormick ◽  
Jeanna M. Wheeler ◽  
Chris R. Guthrie ◽  
Nicole F. Liachko ◽  
Brian C. Kraemer
Keyword(s):  
Dopamine D2 Receptor ◽  
D2 Receptor ◽  
Receptor Antagonism ◽  
Dopamine D2 ◽  
Tau Aggregation

The effects of fast-off-D2 receptor antagonism on L-DOPA-induced dyskinesia and psychosis in parkinsonian macaques

2013 ◽  
Vol 43 ◽  
pp. 151-156 ◽  
Author(s):  
James B. Koprich ◽  
Philippe Huot ◽  
Susan H. Fox ◽  
Keith Jarvie ◽  
Anthony E. Lang ◽  
...  
Keyword(s):  
D2 Receptor ◽  
Receptor Antagonism

SLV310, a Novel, Potential Antipsychotic, Combining Potent Dopamine D2 Receptor Antagonism with Serotonin Reuptake Inhibition.

ChemInform ◽  
2003 ◽  
Vol 34 (22) ◽  
Author(s):  
Rolf van Hes ◽  
Pieter Smid ◽  
Cees N. J. Stroomer ◽  
Koos Tipker ◽  
Martin Th. M. Tulp ◽  
...  
Keyword(s):  
Serotonin Reuptake ◽  
Dopamine D2 Receptor ◽  
D2 Receptor ◽  
Receptor Antagonism ◽  
Dopamine D2 ◽  
Reuptake Inhibition
Sign in / Sign up

Export Citation Format

Share Document